Cyclosporine does not abrogate donor-specific class Ii expression in allografted human heart
Rose, M.; Navarette, C.; Yacoub, M.; Festenstein, H.
Transplantation Proceedings 20(3 Suppl 3: 333-340
1988
ISSN/ISBN: 0041-1345 PMID: 3291265 Document Number: 316832
Document emailed within 1 workday
Related Documents
Charreau, B.; Coupel, S.; Boulday, G.; Soulillou, J.P. 2000: Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene Transplantation 70(2): 354-361Ippoliti, G.; Lazzaro, A.; Goggi, C.; Malavasi, F.; Di Franco, L.; Martinelli, L.; Ascari, E.; Vigano', M. 1989: Expression of class i and class Ii major histocompatibility complex (MHC) antigens in rejecting human heart grafts Transplantation Proceedings 21(1 Part 1): 445-446
Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Taniguchi, M.; Rebellato, L.M.; Briley, K.P.; Haisch, C.E.; Bolin, P.; Banuelos, N.; Hopfield, J.; Terasaki, P.I.; Everly, M.J. 2015: Risk Stratification of Human Leukocyte Antigen Class II Donor Specific Antibody Positive Patients by Immunoglobulin G Subclasses Clinical Transplants 31: 293-301
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Toma, H.; Tanabe, K.; Oba, S.; Horita, S.; Takahashi, K.; Teraoka, S.; Ota, K. 1987: Expression of class Ii antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity Transplantation Proceedings 19(5): 3719-3720
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463
Hillis, A.N.; Duguid, J.; Evans, C.M.; Bone, J.M.; Sells, R.A. 1987: Three year experience of donor specific transfusion and concomitant cyclosporine a Transplantation Proceedings 19(1 Part 3): 2248-2249
Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Monaco, A.P.; Wood, M.L.; Maki, T.; Hartner, W.; De Fazio, S.; Gozzo, J.J. 1988: Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow Transplantation Proceedings 20(3 Suppl 3): 36-48
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A. 1989: Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells Transplantation Proceedings 21(1 Pt 1): 478-479
Oluwole, S.F.; Fawwaz, R.A.; Reemtsma, K.; Hardy, M.A. 1988: The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine Transplantation Proceedings 20(3 Suppl 3: 1038-1044
Lu, Y.; Boss, J.M.; Hu, S.X.; Xu, H.J.; Blanck, G. 1996: Apoptosis-independent retinoblastoma protein rescue of HLA class Ii messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class Ii expression associated with a specific defect in HLA-DRA induction Journal of Immunology 156(7): 2495-2502
Gores, P.F.; Sitges-Serra, A.; Hesse, U.J.; Najarian, J.S.; Sutherland, D.E. 1987: Pretransplant transfusion of donor-specific class i major histocompatibility complex antigen in dogs Transplantation Proceedings 19(1 Part 2): 1407-1408
Taylor, P.M.; Rose, M.L.; Yacoub, M. 1989: Expression of class i and class Ii MHC antigens in normal and transplanted human lung Transplantation Proceedings 21(1 Part 1): 451-452
Zeng, Y.; Torres, M.; Wang, Y.; Montag, A.; Thistlethwaite, J.R. 1995: Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class Ii peptides Transplantation Proceedings 27(1): 176-177
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Ijzermans, J.N.; Bouwman, E.; Jeekel, J.; Marquet, R.L. 1990: Donor pretreatment with IFN-gamma enhances MHC class Ii antigen expression and accelerates graft rejection by modified recipients Transplantation Proceedings 22(4): 1941-1942
Laufer, T.M.; Smiley, S.T.; Ranger, A.; Clements, V.K.; Ostrand-Rosenberg, S.; Glimcher, L.H. 1997: Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation Journal of Immunology 159(12): 5914-5920